CAPPATO, RICCARDO
 Distribuzione geografica
Continente #
NA - Nord America 957
EU - Europa 399
AS - Asia 277
AF - Africa 59
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 1.702
Nazione #
US - Stati Uniti d'America 953
CN - Cina 142
FI - Finlandia 134
SG - Singapore 103
IE - Irlanda 59
NG - Nigeria 57
DE - Germania 49
FR - Francia 37
SE - Svezia 36
NL - Olanda 27
IT - Italia 24
GB - Regno Unito 13
IN - India 8
IL - Israele 7
BD - Bangladesh 5
CA - Canada 4
IQ - Iraq 4
RU - Federazione Russa 4
CZ - Repubblica Ceca 3
IR - Iran 3
JP - Giappone 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
EG - Egitto 2
GR - Grecia 2
NO - Norvegia 2
RO - Romania 2
UA - Ucraina 2
AU - Australia 1
BE - Belgio 1
BR - Brasile 1
CL - Cile 1
ES - Italia 1
EU - Europa 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TR - Turchia 1
Totale 1.702
Città #
San Mateo 162
Wilmington 151
Shanghai 140
Helsinki 134
Chandler 121
Lawrence 73
Princeton 73
Singapore 70
Dublin 59
Benin City 57
Paris 37
Ashburn 31
Amsterdam 27
New York 26
London 11
Fairfield 10
Abbiategrasso 9
Boardman 9
Norwalk 9
Woodbridge 9
Santa Clara 7
Hanover 6
Milan 6
Monmouth Junction 6
Phoenix 6
Des Moines 5
Falkenstein 5
Leawood 5
Los Angeles 5
Clearwater 4
Seattle 4
Andover 3
Barquisimeto 3
Moscow 3
Mumbai 3
Pune 3
Brno 2
Cairo 2
Hangzhou 2
La Canada Flintridge 2
Montreal 2
Otemachi 2
Redmond 2
Sacramento 2
San Diego 2
American Fork 1
Ann Arbor 1
Armilla 1
Augusta 1
Brussels 1
Caloocan City 1
Cambridge 1
Canary Wharf 1
Chisinau 1
Christchurch 1
El Segundo 1
Elk Grove Village 1
Goiânia 1
Gunzenhausen 1
Henderson 1
Kanuma 1
Kocaeli 1
Leeds 1
Olomouc 1
Oslo 1
Pitesti 1
Rome 1
Saint Louis 1
Tempe 1
Toronto 1
Vancouver 1
Winnipeg 1
Totale 1.337
Nome #
A gain-of-function mutation in the cardiac pacemaker HCN4 channel increasing cAMP sensitivity is associated with familial Inappropriate Sinus Tachycardia 54
Data for short and long-term prothrombotic biomarkers after cryoballoon and radiofrequency ablation 52
Complications of catheter ablation: incidence, diagnosis and clinical management 41
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary 41
The subcutaneous implantable cardioverter-defibrillator: Current trends in clinical practice between guidelines and technology progress 39
European Cardiac Arrhythmia Society Statement on the cardiovascular events associated with the use or abuse of energy drinks 37
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation 37
Concurrent electrocardiographic repolarization abnormalities: What is the underlying channelopathy? 37
Catheter ablation of atrial tachycardia in a patient with extracardiac Fontan repair: The utility of transaortic approach and pulmonary artery recording 36
Adenosine and Preexcitation Variants: Reappraisal of Electrocardiographic Changes 35
The Entirely Subcutaneous Defibrillator - A New Generation and Future Expectations 34
Sudden unexpected cardiac death as the first symptom in young people: some useful clinical information from a systematic standardized anatomical study 34
Discordant junctional beats and preexcitation: what is the mechanism? 34
Challenging arrhythmias in a Wolff-Parkinson-White patient: Different physiology and adjacent troubles 33
Exploring unmet needs in venous and arterial thromboembolism with rivaroxaban 32
Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation 30
Para-Hisian pacing maneuver: A pitfall in the pitfall 30
The Year in Cardiology 2016: arrhythmias and cardiac implantable electronic devices 30
Clinical and electrocardiographic features of complete heart block after blunt cardiac injury: A systematic review of the literature 30
Edoxaban in atrial fibrillation patients with established coronary artery disease: Insights from ENGAGE AF-TIMI 48 29
An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-T MRI in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator 29
Efficacy and safety of rivaroxaban compared with vitamin K antagonists for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis 28
An unusual case of acute respiratory failure in a patient with pulmonary veins stenosis late after catheter ablation of atrial fibrillation: a case report and the review of the literature 27
A narrow QRS tachycardia and cannon A waves: What is the mechanism? 27
An unusual WPW syndrome: What is the preexcitation variant? 26
Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial 24
Mechanical Block of a Manifested Accessory Pathway: What Is the Preexcitation Variant? 24
An unusual pattern of Para-Hisian pacing: The role of infra-Hisian conduction delay 23
An Unusual Pattern of Ventricular Pre-Excitation: Electrophysiological and Genetic Substrate 23
Commotio Cordis and complete heart block: Where is the block level? 23
Nodo- and fasciculoventricular pathways: Electrophysiological features and a proposed diagnostic algorithm for preexcitation variants 22
Survival Benefit of the Primary Prevention Implantable Cardioverter-Defibrillator Among Older Patients 22
Pulmonary Vein Stenosis Following Radiofrequency Ablation of Atrial Fibrillation: Has It Become a Clinically Negligible Complication? 22
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants After Cardioversion for Nonvalvular Atrial Fibrillation 22
An Unusual Case of Complete AV Block 22
One for All - All for One: Different Patterns of AV Block in a Patient With Bifascicular Block 22
Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF) 21
Longevity of the Subcutaneous Implantable Defibrillator: Long-Term Follow-Up of the European Regulatory Trial Cohort 21
The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability 21
An unexpected cause of wide QRS tachycardia in a young woman 21
An Uncommon Block of a Common Circuit 21
Tailored treatment strategies: a new approach for modern management of atrial fibrillation 21
Junctional Beats and Short HV Interval: What More Do You Need? 21
Real-world evidence of stroke prevention in patients with nonvalvular atrial fibrillation in the United States: the REVISIT-US study 21
Junctional beats and pure His bundle pacing: Surface ECG appraisal in an atypical preexcitation variant 20
Long-Term Results of Cryoballoon Ablation for Atrial Fibrillation: Confirmation of an Early Promise 20
Small reentry in a mega coronary sinus: Anatomical and high-density activation mapping 20
Lower dose direct oral anticoagulants and improved survival: A combined analysis in patients with established atherosclerosis 20
Introduction 19
Right Bundle Branch Block as a Potential Cause of Pacemaker Malfunction 19
Sudden cardiac death: New approaches for implantable cardioverter-defibrillators (ICDs) 19
Para-CS pacing maneuver: further evidence of left atrionodal connections 19
Nearly fatal ventricular arrhythmia following pacemaker implantation in a young female with complete heart block 18
Supraventricular arrhythmia with discordant electrocardiographic features: What is the arrhythmia mechanism? 18
Notch Filtering of Intracardiac Recordings: Improving Quality or Masking Reality? 18
Short and long-term changes in platelet and inflammatory biomarkers after cryoballoon and radiofrequency ablation 17
When to choose cardiac resynchronization therapy in chronic heart failure: type and duration of the conduction delay 17
Patient-reported treatment satisfaction and budget impact with rivaroxaban vs. standard therapy in elective cardioversion of atrial fibrillation: apost hocanalysis of the X-VeRT trial 17
Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies 17
Is It Complete Left Bundle Branch Block? Just Ablate the Right Bundle 17
Premature ventricular extrastimulus without His or ventricular capture: An unexpected response during AV nodal reentrant tachycardia 17
Implantable cardioverter-defibrillators in heart failure patients with reduced ejection fraction and diabetes 17
Left atrial thrombus resolution in non-valvular atrial fibrillation or flutter: biomarker substudy results from a prospective study with rivaroxaban (X-TRA) 17
New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials 17
Treatment of inappropriate sinus tachycardia with ivabradine 17
Long-Term Follow-Up of Idiopathic Ventricular Fibrillation in a Pediatric Population: Clinical Characteristics, Management, and Complications 16
Repetitive wide-QRS arrhythmia after remote myocarditis: What is the mechanism? 16
Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF) 16
Negative concordance pattern in bipolar and unipolar recordings: An additional mapping criterion to localize the site of origin of focal ventricular arrhythmias 16
Predicting appropriate shocks in patients with heart failure: Patient level meta-analysis from SCD-HeFT and MADIT II 16
Long-term follow-up after radiofrequency ablation of ectopic atrial tachycardia in young patients 16
Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study 16
Para-Hisian Pacing: New Insights of an Old Pacing Maneuver 13
European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1- epidemiology, pathophysiology, and diagnosis 12
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2 - care pathways, treatment, and follow-up 12
Totale 1.808
Categoria #
all - tutte 20.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.522


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021288 0 0 0 0 0 0 1 1 113 78 0 95
2021/2022393 12 0 5 67 2 1 11 62 28 65 108 32
2022/2023574 161 3 75 11 38 28 4 41 97 79 28 9
2023/2024529 19 81 81 12 19 48 63 51 9 8 50 88
2024/202524 17 7 0 0 0 0 0 0 0 0 0 0
Totale 1.808